Mandate

Vinge has assisted Priveq in connection with the formation of Priveq Investment VII

June 04, 2024 Private Funds

Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, Priveq Investment VII, at SEK 3 billion. The fund’s first and final closing was significantly oversubscribed with strong backing from existing investors and substantial interest from new institutional investors.


The fund’s investor base consists of a diversified group of Nordic, European and North American investors including public and private pension funds, insurance companies, charitable foundations, endowments, public institutions, family offices and fund-of-funds.

Vinge has assisted Priveq as Swedish legal counsel in connection with the fund formation.

Vinge's team consisted of Mattias Schömer, Marcus Andersson, Nils Unckel, Anton Sjökvist, Emelie Svanberg, Tobias Onegård Karlsson, Semir Omerbasic, Emelie Zingmark, Helena Göransson, Nour Makie and Elias Kröger.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026